MedTrace Logo

Transoesophageal Echocardiography in Liver Transplantation

NCT00547924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2014-04-10

No results posted yet for this study

Summary

Severe hypotension during reperfusion in liver transplantation is a frequent adverse event. Rare data exist so far about pathophysiology of this phenomenon. The exact role of left ventricular function, which might be impaired causing hypotension, has not been elucidated during the period of reperfusion.

Goal of this study is to:

* perform transesophageal echocardiography in order to assess systolic and diastolic left ventricular function during reperfusion
* determine inflammatory mediators in the plasma which could cause left ventricular dysfunction

Conditions

  • End Stage Liver Disease

Interventions

BEHAVIORAL

Transoesophageal echocardiography

Transoesophageal echocardiography in liver transplantation: left ventricular function during reperfusion

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Marco Zalunardo, MD · UniversitaetsSpital Zuerich

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00547924 on ClinicalTrials.gov